Clinical situations are complex

We are excited to announce our new immunohematology tool that evaluates positive direct antiglobulin test (DAT) samples in gel technology. DG Gel DC Scan Plus investigates those clinical situations where the presence of hemolysis has been established, or is suspected, to distinguish immune from nonimmune hemolytic anemia, to help determine the best treatment in each case.

DG Gel DC Scan Plus improves patient care by extending the specificity of the DAT reagents beyond routine anti-IgG and anti-C3d, increasing sensitivity and specificity, and improving clinical patient management and outcomes in AIHA. Furthermore, it unifies and simplifies testing protocols to help you make the right decision based on diagnostic evidence. Timely results increase your efficiency and let you start the appropriate treatment and avoid undesired situations.

Click here to learn more

IVD product bearing CE mark certification under the IVDR.